GSK resolves patent lawsuit against Pfizer over RSV vaccines
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
FTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs
FTSE 100 p harma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...
FDA greenlights GSK’s drug for UTIs in women and girls
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
GSK slides Wednesday, underperforms market
GSK PLC closed 21.39% short of its 52-week high of £18.24, which the company reached on May 16th.
GSK falls Monday, underperforms market
GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops
A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.